Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic vs Empirical Vancomycin for Streptococcal Sepsis in HSCT
NCT00138112Phase 3Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Nov 2003
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vancomycin in viridans streptococcal bacteremia (2 arms), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Incidence of early viridans streptococcal bacteremia. Started Nov 2003; status: completed.
02
Drugs
vancomycin
03
Conditions
viridans streptococcal bacteremia
Beyond the preview
Go deeper on NCT00138112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00138112.